[Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)].
L V StakhovskayaE A MhitaryanOlga N TkachevaT M OstroumovaOlga Dmitrievna OstroumovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
It is recommended to include mexidol in therapy of patients with IS in the acute and early rehabilitation stages in all age groups, including patients with DM.
Keyphrases
- double blind
- liver failure
- clinical trial
- phase iii
- respiratory failure
- placebo controlled
- study protocol
- phase ii
- drug induced
- aortic dissection
- atrial fibrillation
- hepatitis b virus
- randomized controlled trial
- intensive care unit
- cross sectional
- mesenchymal stem cells
- adipose tissue
- insulin resistance
- skeletal muscle
- replacement therapy